Jenny Gorin

442 total citations
8 papers, 375 citations indexed

About

Jenny Gorin is a scholar working on Oncology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jenny Gorin has authored 8 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Biomaterials and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jenny Gorin's work include Nanoparticle-Based Drug Delivery (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Bone health and treatments (4 papers). Jenny Gorin is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Bone health and treatments (4 papers). Jenny Gorin collaborates with scholars based in Israel and United States. Jenny Gorin's co-authors include Yasmine Amitay, Alberto Gabizón, Dina Tzemach, Hilary Shmeeda, Lidia Mak, Samuel Zalipsky, Saran Kumar, Patricia Ohana, Stęphan T. Stern and Yechezkel Barenholz and has published in prestigious journals such as Journal of Controlled Release, Pharmaceutical Research and Molecular Cancer Therapeutics.

In The Last Decade

Jenny Gorin

8 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Gorin Israel 7 211 159 128 100 66 8 375
Kiran R. Chaudhari India 7 255 1.2× 253 1.6× 179 1.4× 129 1.3× 87 1.3× 8 529
Yasmine Amitay Israel 13 382 1.8× 309 1.9× 230 1.8× 133 1.3× 88 1.3× 17 644
Juan J. Arroyo‐Crespo Spain 7 164 0.8× 150 0.9× 140 1.1× 63 0.6× 21 0.3× 9 366
Lidia Mak Israel 9 395 1.9× 278 1.7× 232 1.8× 114 1.1× 68 1.0× 11 589
Donald M. Parsons United States 4 201 1.0× 109 0.7× 158 1.2× 48 0.5× 22 0.3× 6 351
Hayley Nehoff New Zealand 3 272 1.3× 165 1.0× 221 1.7× 49 0.5× 27 0.4× 3 466
Danika Rodrigues United States 8 125 0.6× 140 0.9× 206 1.6× 60 0.6× 37 0.6× 10 417
Jason Kato United States 7 223 1.1× 156 1.0× 141 1.1× 49 0.5× 40 0.6× 8 389
Dianlong Jia China 12 80 0.4× 180 1.1× 104 0.8× 79 0.8× 77 1.2× 27 357
Chad A. Walden United States 6 219 1.0× 163 1.0× 168 1.3× 41 0.4× 24 0.4× 6 442

Countries citing papers authored by Jenny Gorin

Since Specialization
Citations

This map shows the geographic impact of Jenny Gorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Gorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Gorin more than expected).

Fields of papers citing papers by Jenny Gorin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Gorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Gorin. The network helps show where Jenny Gorin may publish in the future.

Co-authorship network of co-authors of Jenny Gorin

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Gorin. A scholar is included among the top collaborators of Jenny Gorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Gorin. Jenny Gorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gabizón, Alberto, Patricia Ohana, Yasmine Amitay, et al.. (2021). Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy. Cancer Drug Resistance. 4(2). 463–484. 11 indexed citations
2.
Shmeeda, Hilary, Yasmine Amitay, Jenny Gorin, et al.. (2016). Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer. Journal of drug targeting. 24(9). 878–889. 38 indexed citations
3.
Amitay, Yasmine, Hilary Shmeeda, Yogita P. Patil, et al.. (2015). Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues. Pharmaceutical Research. 33(3). 686–700. 33 indexed citations
4.
Shmeeda, Hilary, Yasmine Amitay, Dina Tzemach, Jenny Gorin, & Alberto Gabizón. (2013). Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity. Journal of Controlled Release. 167(3). 265–275. 64 indexed citations
5.
Gabizón, Alberto, Yasmine Amitay, Dina Tzemach, et al.. (2011). Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: Studies with human gastro-entero-pancreatic ectopic tumor models. Journal of Controlled Release. 160(2). 245–253. 52 indexed citations
6.
Shmeeda, Hilary, Yasmine Amitay, Jenny Gorin, et al.. (2010). Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells. Journal of Controlled Release. 146(1). 76–83. 77 indexed citations
7.
Gabizón, Alberto, Dina Tzemach, Jenny Gorin, et al.. (2009). Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Cancer Chemotherapy and Pharmacology. 66(1). 43–52. 99 indexed citations
8.
Shmeeda, Hilary, Jenny Gorin, Lidia Mak, et al.. (2007). Intracellular delivery of liposome-encapsulated zoledronic acid via folate receptor results in significant inhibition of tumor cell growth. Molecular Cancer Therapeutics. 6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026